Member Info for JustHereForHemo

I wont pollute the site with any more personal attacks, end up getting banned! HT, believe what you want to believe, but when I have doubts I seek clarification same as many others, if its not in an interview then idc? "Peterpharma" in the very very small possibility that you are some new poster to Hemo on LSE and have never posted before then my sincere apologies. HOWEVER its much more likely that you are just one more re-incarnation of our trolls who have been plaguing Hemo for years. Is it possible your not? Everything is possible, but I doubt it.

The reason for my aggression is because yet again, at this point, this very important and key moment in the history of Hemogenyx, when within probably days a whole bunch of trolls land up and just decide once again to attack the company. They could chose to try and make money by investing and riding the wave that is inevitable with the publicity around first injection but instead nope. I will catch you all on Monday, as much as I am addicted to LSE my boss has arrived with a company credit card...... Have a good weekend!

Or maybe your really not that happy that Hemo FINALLY are going "Real Life" Clinical and are fully aware of the fact that once that happens the increase volume and attention means you and your army of fake profiles wont be able to run rough shod over shareholders and manipulate the SP any more?

Tick F'ing Tock you disgusting piece of filth who has dedicated years attacking a company who are about to save lives.

You worthless piece of trash who has put small profits for yourself ahead of Hemogenyx being in a strong position to accelerate research.

I have total faith in Hemogenyx, and in a very very strong bounce and while on many sites like this people pledge to donate to charity speak to anyone I speak to in private, I have pledged for a long time to spend a decent chunk on a solicitor to hound the FCA, to pursue the traders and trolls who have used insider trading and market manipulation hiding behind fake profiles to attack hemo over the years. You know EXACTLY the damage you and your ilk have done here over the years and how much stronger a position this company would be if you (collectively) had not shorted and traded. How much more advanced research in CDX and CBR would be, but its ok, you made a few quid.

And you accuse people of being rude? Its all I can do to restrain myself from calling you and the other trolls what I really think of you, I have utter contempt and disgust that so many people would dedicate so much time and effort and money to attack a company like hemogenyx knowing 100% the side effect is Human lives that could be saved wont due to delays from lack of funding over the years. You pathetic worm.

Have you checked interviews, Vlads linked in posts etc? I am certain multiple people posted here because the https://www.lse.co.uk/rns/HEMO/placing-to-raise-163340000-47uvhmg3veb9c91.html was not exactly clear.

In the interests of being accused of dismissing legitimate discussion, here is a link to what he is talking about:

https://www.mdanderson.org/cancerwise/need-car-t-cell-therapy--here-is-what-to-expect-what-happens-during-car-t-cell-therapy.h00-159615489.html

Extracting the T cells (apheresis) Is done AFTER insurance approval as this is an expensive process. In the last update Vlad made it clear that the sample had already been drawn from the patient and was being tested for suitability. That puts us at that point in the 3 week "Enhancing the T cells:" Stage.

Based strictly on MDAnderson printed timeline on their website, puts "Infusing the CAR T cells" next week. This is not ramping/pumping/inside information. The timeline provided by MDA, as quoted by our troll, has the infusion early next week. Its the FIRST patient for HG-CT-1 so slipping a week or so is entirely possible, but again MDA know what they are doing so next week is also entirely possible. Traders work away, your money your gambling.

Lets wittle this list of potential candidates down to 1, select the patient, spend all our resources making sure they are suitable, start manufacturing the CAR-T..... Oh wait!!! Lets pick now to go and call the insurers, GEE I hope they dont say no or thats weeks and thousands of pounds wasted we cant claim back!!!! Seriously.

LST I mean HT was saying it should have been 2 weeks ago, was just saying that ontop of the 10 days manufacturing you have to allow days each side for testing + patient conditioning. So it really could be any time at this point.

"Peterpharma" - Anyone give a flying fudge who it really is? No? Ok. Is talking irrelevant BS, the "insurance approval" funny enough comes BEFORE they start manufacturing the CAR-T, this is one of the most idiotic attack vectors I have seen, seriously you think MDA and Hemo are going to move onto the manufacturing stage and THEN ring up the insurance company who will say "Nope, not paying". Vlad and MDA have a chin wag and say "Ah well, throw it all away..." Wise up, atleast stick to the good ole fashioned "Placing!! No money!!" attack.

They said they had to test the blood product first to make sure it was suitable, and then after they manufacture the CAR-T it has to be tested. And once the CAR-T is available they have to condition the patient which takes a few days before the infusion. So add all that together and your talking another few weeks, but yes I agree it should be pretty soon!

2n6 is pointing out that Dr Vladislav Sandler has achieved with 20m what other companies have needed hundreds of millions to achieve. What Hemogenyx have achieved on such a tiny shoe string is something that in future will blow minds. To do this for HG-CT-1 alone would be amazing. To ALSO develop CDX to pre IND stage and CBR? With the potential it has??? All for 20m?

Staggering. Thank you tuan for reminding us, when I look at the percentage of this company that I own.

When I look at the competition valuation.

When I calculate the potential returns....

I get chills.

Stu is back lol, well stu if you start posting BS to try and scare people off ill be posting more, if you have bought in and are not here to troll I'll be posting less. So it's really up to you

Shoot, 28£ yea, I had 5 in my head from the warrants! I'm done, got it out of my system for a few days :-)

The fact is if Hemogenyx had 10m in the bank then this would not be a binary play, CDX and CBR are much bigger than CAR-T and if they had money would be progressing just as fast. Everything in Hemo comes down to a binary play because either it works and they scrape though to the next phase or they need additional funds to carry on as it is always down to the spare change. Time and money are the issue here as always.... For now.

Haywain IS an expert in this field and he can tell us the percentages, but reality is the chances of HG-CT-1 moving through phase 1 is like 90%+ so there is a small chance of failure/clinical hold/abandonment, so 2 outcomes, its binary, flip a bottle 10 times and one of those times it may land on the cap, thats binary.

For the past 7 years the main thing that has been used to troll and attack is ALWAYS money, except 121 who smokes crack... But most of the troll always come at us with "But placing!" And that is ONLY effective because of the low mCap meaning higher dilution and discounts through peterhouse.

Peterhouse are NOT doing more placings here, every one of them have screwed us compared to the recent relative success of SP Angel, they can have hurt feelings all they want and decide not to tell any of their clients to buy for a trade, whoopie do, we are better off. Going clinical with first patient is a massive jump from FDA approval, which 12 months ago took us to 7p, £35 in todays money, only to tank because of yet again a PETERHOUSE SPECIAL.

This trial IS starting, the chances are its gonna work and this is going to attract significant numbers of new buyers, forget about CDX or CBR or licensing, JUST new investors wanting to gamble on the CAR-T working. From such a low mCap its incredibly easy to multi bag and when that happens? Suddenly the years of funding fear go away as well as Vlad can easily hit up the US investors for a few mil AND we have a trader with 50k warrants at £5 which is £250k we should see converted.

So for all those who are just pure exhausted due to the time this has taken, to the people who look at a board of red trades and think "Why is everyone selling???" *(Hint, most of them are buys, the SP is up despite what LSE prints). For those who are crying where is everyone??? Forget about LSE. Go and google licensing deals for CAR-T, look at the success rates of CAR-T, look at the RNS's and look for debt and warrants. Hemogenyx is sitting in an incredibly strong position right now, the potential to explode has never been stronger and it all hinges on one thing.... Will people notice Hemogenyx when they treat that first HUMAN patient suffering with AML? Will Hemo for the first time in 7 years take the spotlight?

If your answer is no then sell, if your answer is yes? Hold on to your hat.

#YesIAmExcited.

Peter, realistically there are 3 possibilities here:

1, The most likely based on percentages is that the patient takes the infusion and carries on 30 days with no major side effects. They picked the best candidate out of a big pool and this is the most likely outcome or they would not have gotten approval to start the trial.

2, Before the patient is able to take the infusion they are deemed too ill to continue, this would be bad for the patient and frustrating for us as it means another few weeks waiting for patient selection and CAR-T manufacturing again. It would not be a wipeout as it would not have anything to do with Hemo but more the patients health.

3, The patient takes the infusion and there are negative side effects and the FDA apply a clinical hold, this would be bad but again, IMO its the least likely of the 3 options.

Micky, I understand its frustrating but Vlad has explained the process and he did say there was not alot he can say during this time, they cannot keep giving updates on the patient as they are likely reading this board and its private about them. But I do know alot of people have been contacting hemo asking for updates and some have been told they will try and do something so maybe an interview to confirm the process is still going? I really dont know but I do know KP posted yesterday saying he had a positive email from Vlad so that is good :-)

Very true Micky every day is a day more salaries that have to be paid, but again, 15 days ago they received £340,000 cash in the bank.... That is enough for 2 months, so is it your opinion that the SP is going to sit here for 2 months while the company transition through what should be the biggest single event in their history? FWIW I expect a very significant rise in SP and volume on first injection and based on the fact the placee is currently selling that would indicate they want to keep below 3% if they convert their warrants which I fully expect them to do when this goes north of £5, that would be an additional £250k injection of cash into Hemogenyx.

To say "Still no progress" is incredibly disingenuous as you know full well that it takes a few weeks to prepare the CAR-T treatment today. Waiting for it to be manufactured is NOT no progress.

I think Saint is having a bit of fun with you Peter :-) Reality is I dont think any LTH on here would expect to get an answer to that question via email, be lucky to get an email confirming their office is in the US :P

I think its safe to assume they had passed the insurance step as they had collected the cells and were testing them for suitability prior to manufacture, based on the timeline you provided this would necessitate coming AFTER "Extracting the T cells" which puts them at this stage:

"Enhancing the T cells: 3 weeks. That’s generally how long it takes for T cells to be sent to the lab, altered and returned to MD Anderson."

On that basis, next week is entirely possible but as its the first time if it slips a week then so be it, at this point I its looking less likely they will update us before first injection, always possible with Vlad but just keep checking daily for an RNS as that could be the big one.

Remember 1 year ago Hemo got FDA approval and went to 7p/£28 p/s. There has been some dilution but only around 20% which when you consider this is the first actual human trial and not just approval to start the trial process.... Very surprised we have not seen alot more traders here, given the low mCap and magnitude of the update coming would expect ALOT of interest in the very near future.

Hemo, Prevail, MDAnderson have chosen one patient and Hemogenyx are preparing the HG-CT-1 treatment. That's as much as we know or will ever need to know, personal details such as how much they have to pay are irrelevant to us and I doubt we will ever k ow.

Lol, have to pinch myself daily to make sure ;-)

It is absolute madness, but its not entirely without precedent, there are plenty of companies out there that basically flatlined their entire existence until one day vertical line. The share does not have the attention or volume to do much as it stands, any buying is not enough to outweigh past placees flipping or traders selling or shorting. We need the volume we last saw one year ago when it shot up to 7p, or several years ago when it went up to 14p. This has happened twice in the life of Hemogenyx, FDA approval was the last one, there is some debate around will the next one be first injection or first results but for me there is no real debate. FDA approval to start trials was not test results, it was the promise that Hemo are going clinical and have the potential to generate positive results. That is the same as first injection, it has the potential in very short term to yield positive results. The FDA approval was swiftly followed by a very large peterhouse special after a market sounding, this time that is not happening, Vlad has FINALLY accepted that using peterhouse for fundraising is akin to asking matt gaetz to baby sit your teenage daughter and expecting a different outcome each time. Imagine where we would be today had he just stuck with SP Angel.

Only one has printed StockWatching, but nice of you to put your hands up.

Realistically you will still make a decent profit waiting and you avoid that risk. So I won't criticise anyone making that decision. But you buy before and the potential is much greater, but so is the risk.

Nemethv to be clear when you say the CEO shafting investors your referring to the CEO raising 20m over the last 7 odd years and getting CAR-T into human trials. Never mind CDX and CBR? Companies list to raise funds, the CEO has not shafted anyone, if people want to know who to blame then you don't have to look far, the traders screaming placing every 6 to 12 months, the placees who sell and short and push the sp as low as possible to hurt the company for a few extra quid. They are to blame, the entire London small cap market is broken by these leeches. Vlads biggest mistake was taking so long to accept the reality, you cannot raise from the likes of peterhouse without seeing your value destroyed. Market doesn't trust the CEO? Bs, more like the market don't like that Vlad has turned his back on retail traders. The usual traders we have seen for years are silent because we all know half of them were inside for placings and could trade with impunity and advance warning.

Those days are over. Volume is dead, even now days from first infusion, the penny traders are staying away, GOOD! Every single one of them would sell on news anyway, I'd rather see us rise slowly as LTHers like myself nibble away as many as we can. We are not after 10%.

First infusion is not just another update. When it happens one way or another we will know within weeks or a month, no clinical hold and we are off to the races.

A few people here can appreciate the potential and value, the traders can't and will never accept that hemo should be worth 100s of millions. Reality is HG-CT-1 is a known product, it's targeting AML, demand is high, we know what CAR-T is worth. We are talking 500m-1bn.

The future here is going to save lives and change lives and if people want to sit it out because in the past he trusted his brokers??? Fine! 👋

But before you put all the blame on Vlads plate just remember he was acting on the guidance of his advisors all this time. Going to the US is NOT what peterhouse want, they would prefer to keep milking the peterhouse special tree and us shareholders. Things have changed, the future is increasingly looking bright and the time frame to get on board is shrinking fast.

Cross ramping IMM on Hemogenyx? Wise up. I'm sure this will do well but seriously. Hemo have selected and tested their patient for their first ever human trial of their CAR-T against AML, so first infusion is days or 2-3 weeks max. So I would almost guarantee it will do orders of magnitude better than IMM over that time span. Why am I saying this here? Because people from here are out there cross ramping on other stocks. Behave and keep your ramping to this board please.